JCR Pharmaceuticals (OTCMKTS:JCRRF) Trading Up 5.2% – Here’s What Happened

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) traded up 5.2% during trading on Thursday . The stock traded as high as $3.31 and last traded at $3.31. Approximately 476 shares traded hands during trading, a decline of 5% from the average session volume of 500 shares. The stock had previously closed at $3.1450.

JCR Pharmaceuticals Stock Performance

The stock’s 50 day moving average price is $3.68 and its two-hundred day moving average price is $4.12.

JCR Pharmaceuticals Company Profile

(Get Free Report)

JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.

In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.

Featured Articles

• Five stocks we like better than JCR Pharmaceuticals
• Shorting the Grid: Bloom Energy’s $25B AI Power Play
• SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
• Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
• 3 Dividend ETFs Built for Stability in a Volatile Market